The generation of mutant Hmcn1 and Hmcn2 knock-in mouse models or the transgenic overexpression of mutant Hmcn1 and Hmcn2 variants may allow to test whether such dominant negative effects of mutant Hemicentins may phenocopy Fraser syndrome-like features in mice. This evidence concerns the gene HMCN2 and Fraser syndrome.